Sign inGet started

SIOX

Sio Gene Therapies Inc.CIK 1636050 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
9

AI insights for SIOX PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for SIOX
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Meswani Parag VChief Commercial Officer1$0$02022-02-08
Nassif David W.Interim CEO, CFO7$0$02022-02-08
Cheruvu PavanChief Executive Officer7$248.0K$02021-12-08
Sundaram Senthil VelDirector1$0$02021-04-15
Corcoran GavinChief R&D Officer3$0$02021-04-15
Torti FrankDirector1$0$02021-04-15
Modig BerndtDirector1$0$02021-04-15
Pande AtulDirector2$23.4K$02021-04-15
Vuori Kristiina MDDirector1$0$02021-04-15

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Nassif David W.Interim CEO, CFO A Award deriv2022-02-082022-02-10546,500— $0546,500SEC↗
Meswani Parag VChief Commercial Officer A Award deriv2022-02-082022-02-10153,700— $0153,700SEC↗
Cheruvu PavanChief Executive Officer D To issuer deriv2021-12-082021-12-0937,567— $075,133SEC↗
Nassif David W.Chief Financial Officer D To issuer deriv2021-12-082021-12-0917,534— $035,066SEC↗
Cheruvu PavanChief Executive Officer F Tax w/h2021-12-082021-12-0914,884$1.42 $21.1K203,109SEC↗
Cheruvu PavanChief Executive Officer A Award2021-12-082021-12-0937,567— $0217,993SEC↗
Nassif David W.Chief Financial Officer F Tax w/h2021-12-082021-12-096,294$1.42 $8.9K45,244SEC↗
Nassif David W.Chief Financial Officer A Award2021-12-082021-12-0917,534— $051,538SEC↗
Cheruvu PavanChief Executive Officer A Award deriv2021-04-152021-04-19682,100— $0682,100SEC↗
Corcoran GavinChief R&D Officer A Award deriv2021-04-152021-04-19244,300— $0244,300SEC↗
Nassif David W.Chief Financial Officer A Award deriv2021-04-152021-04-19239,000— $0239,000SEC↗
Modig BerndtDirector A Award deriv2021-04-152021-04-1942,000— $042,000SEC↗
Pande AtulDirector A Award deriv2021-04-152021-04-1942,000— $042,000SEC↗
Sundaram Senthil VelDirector A Award deriv2021-04-152021-04-1942,000— $042,000SEC↗
Torti FrankDirector A Award deriv2021-04-152021-04-1942,000— $042,000SEC↗
Vuori Kristiina MDDirector A Award deriv2021-04-152021-04-1942,000— $042,000SEC↗
Cheruvu PavanChief Executive Officer P Buy2021-03-232021-03-24100,000$2.48 $248.0K180,426SEC↗
Nassif David W.Chief Financial Officer D To issuer deriv2021-03-222021-03-2215,060— $00SEC↗
Nassif David W.Chief Financial Officer A Award2021-03-222021-03-2215,060— $034,004SEC↗
Cheruvu PavanChief Executive Officer D To issuer deriv2021-03-172021-03-1922,590— $00SEC↗
Corcoran GavinChief R&D Officer D To issuer deriv2021-03-172021-03-1916,001— $00SEC↗
Cheruvu PavanChief Executive Officer A Award2021-03-172021-03-1922,590— $080,426SEC↗
Corcoran GavinChief R&D Officer A Award2021-03-172021-03-1916,001— $025,792SEC↗
Pande AtulDirector P Buy2020-11-242020-11-2510,000$2.34 $23.4K33,370SEC↗